Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Signaling from Mus81-Eme2-Dependent DNA Damage Elicited by Chk1 Deficiency Modulates Replication Fork Speed and Origin Usage.

Técher H, Koundrioukoff S, Carignon S, Wilhelm T, Millot GA, Lopez BS, Brison O, Debatisse M.

Cell Rep. 2016 Feb 9;14(5):1114-1127. doi: 10.1016/j.celrep.2015.12.093. Epub 2016 Jan 21.

2.

Updating the mechanisms of common fragile site instability: how to reconcile the different views?

Le Tallec B, Koundrioukoff S, Wilhelm T, Letessier A, Brison O, Debatisse M.

Cell Mol Life Sci. 2014 Dec;71(23):4489-94. doi: 10.1007/s00018-014-1720-2. Epub 2014 Sep 24. Review.

3.

Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes.

Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, Debatisse M.

Cell Rep. 2013 Aug 15;4(3):420-8. doi: 10.1016/j.celrep.2013.07.003. Epub 2013 Aug 1.

4.

Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity.

Koundrioukoff S, Carignon S, Técher H, Letessier A, Brison O, Debatisse M.

PLoS Genet. 2013;9(7):e1003643. doi: 10.1371/journal.pgen.1003643. Epub 2013 Jul 18.

5.

Characterization at nucleotide resolution of the homogeneously staining region sites of insertion in two cancer cell lines.

Gibaud A, Vogt N, Brison O, Debatisse M, Malfoy B.

Nucleic Acids Res. 2013 Sep;41(17):8210-9. doi: 10.1093/nar/gkt566. Epub 2013 Jul 2.

6.

Replication dynamics: biases and robustness of DNA fiber analysis.

Técher H, Koundrioukoff S, Azar D, Wilhelm T, Carignon S, Brison O, Debatisse M, Le Tallec B.

J Mol Biol. 2013 Nov 29;425(23):4845-55. doi: 10.1016/j.jmb.2013.03.040. Epub 2013 Apr 1.

PMID:
23557832
7.

Common fragile sites: mechanisms of instability revisited.

Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, Brison O.

Trends Genet. 2012 Jan;28(1):22-32. doi: 10.1016/j.tig.2011.10.003. Epub 2011 Nov 15. Review.

PMID:
22094264
8.

Molecular profiling of common fragile sites in human fibroblasts.

Le Tallec B, Dutrillaux B, Lachages AM, Millot GA, Brison O, Debatisse M.

Nat Struct Mol Biol. 2011 Nov 6;18(12):1421-3. doi: 10.1038/nsmb.2155.

PMID:
22056772
9.

Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndrome.

Chabosseau P, Buhagiar-Labarchède G, Onclercq-Delic R, Lambert S, Debatisse M, Brison O, Amor-Guéret M.

Nat Commun. 2011 Jun 28;2:368. doi: 10.1038/ncomms1363.

PMID:
21712816
10.

Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site.

Letessier A, Millot GA, Koundrioukoff S, Lachagès AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M.

Nature. 2011 Feb 3;470(7332):120-3. doi: 10.1038/nature09745. Epub 2011 Jan 23.

PMID:
21258320
11.

Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions.

Gay S, Lachages AM, Millot GA, Courbet S, Letessier A, Debatisse M, Brison O.

EMBO Rep. 2010 Sep;11(9):698-704. doi: 10.1038/embor.2010.112. Epub 2010 Jul 30.

12.

Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.

Guillaud-Bataille M, Brison O, Danglot G, Lavialle C, Raynal B, Lazar V, Dessen P, Bernheim A.

Cytogenet Genome Res. 2009;124(1):1-11. doi: 10.1159/000200082. Epub 2009 Apr 14.

PMID:
19372663
13.

Replication fork movement sets chromatin loop size and origin choice in mammalian cells.

Courbet S, Gay S, Arnoult N, Wronka G, Anglana M, Brison O, Debatisse M.

Nature. 2008 Sep 25;455(7212):557-60. doi: 10.1038/nature07233. Epub 2008 Aug 17.

PMID:
18716622
14.
15.

High frequency trans-splicing in a cell line producing spliced and polyadenylated RNA polymerase I transcripts from an rDNA-myc chimeric gene.

Chen C, Fossar N, Weil D, Guillaud-Bataille M, Danglot G, Raynal B, Dautry F, Bernheim A, Brison O.

Nucleic Acids Res. 2005 Apr 22;33(7):2332-42. Print 2005.

16.
17.

Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.

Valent A, Guillaud-Bataille M, Farra C, Lozach F, Spengler B, Terrier-Lacombe MJ, Valteau-Couanet D, Danglot G, Lenoir GM, Brison O, Bénard J, Bernheim A.

Cancer Genet Cytogenet. 2004 Aug;153(1):10-5.

PMID:
15325088
18.

The 18S rRNA from Odontophrynus americanus 2n and 4n (Amphibia, Anura) reveals unusual extra sequences in the variable region V2.

Alvares LE, Wuyts J, Van de Peer Y, Silva EP, Coutinho LL, Brison O, Ruiz IR.

Genome. 2004 Jun;47(3):421-8.

PMID:
15190359
19.

[Cytogenetics, cytogenomics and cancer: 2004 update].

Bernheim A, Huret JL, Guillaud-Bataille M, Brison O, Couturiers J; Groupe Français de Cytogénétique Oncologique.

Bull Cancer. 2004 Jan;91(1):29-43. Review. French.

20.

Multiple effects of paclitaxel are modulated by a high c-myc amplification level.

Bottone MG, Soldani C, Tognon G, Gorrini C, Lazzè MC, Brison O, Ciomei M, Pellicciari C, Scovassi AI.

Exp Cell Res. 2003 Oct 15;290(1):49-59.

PMID:
14516787
21.

Effect of apoptogenic stimuli on colon carcinoma cell lines with a different c-myc expression level.

Gorrini C, Donzelli M, Torriglia A, Supino R, Brison O, Bernardi R, Negri C, Denegri M, Counis MF, Ranzani GN, Scovassi AI.

Int J Mol Med. 2003 Jun;11(6):737-42.

PMID:
12736715
22.

Megakaryocyte polyploidization is associated with a functional gene amplification.

Raslova H, Roy L, Vourc'h C, Le Couedic JP, Brison O, Metivier D, Feunteun J, Kroemer G, Debili N, Vainchenker W.

Blood. 2003 Jan 15;101(2):541-4. Epub 2002 Sep 5.

PMID:
12393414
23.
24.

Molecular evolution of ribosomal intergenic spacers in Odontophrynus americanus 2n and 4n (Amphibia: Anura).

Alvares LE, Polanco C, Brison O, Coutinho LL, Ruiz IR.

Genome. 2002 Feb;45(1):71-81.

PMID:
11911120
25.

Deregulated expression of the keratin 18 gene in human colon carcinoma cells.

Fossar N, Chaouche M, Prochasson P, Rousset M, Brison O.

Somat Cell Mol Genet. 1999 Jul;25(4):223-35.

PMID:
11586789
26.

T-cell lymphoma with eosinophilia of donor origin occurring 12 years after allogeneic bone marrow transplantation for myeloma.

Rivet J, Moreau D, Daneshpouy M, Schlemmer B, Leleu G, Baumelou E, Rio B, Brison O, Janin A.

Transplantation. 2001 Sep 15;72(5):965. No abstract available.

PMID:
11571470
27.

A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Gunther M, Laithier M, Brison O.

Mol Cell Biochem. 2000 Jul;210(1-2):131-42.

PMID:
10976766
28.

Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line.

Galdemard C, Yamagata H, Brison O, Lavialle C.

J Biol Chem. 2000 Jun 9;275(23):17364-73.

29.

Sequence analysis of the transcription control region upstream of the human FGF-3 gene.

Djenabi S, Brison O, Galdemard C, Lavialle C.

DNA Seq. 1999;10(4-5):317-29.

PMID:
10727086
30.

Transcriptional mechanisms responsible for the overexpression of the keratin 18 gene in cells of a human colon carcinoma cell line.

Prochasson P, Gunther M, Laithier M, Fossar N, Lavialle C, Brison O.

Exp Cell Res. 1999 Apr 10;248(1):243-59.

PMID:
10094831
32.

Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.

Donzelli M, Bernardi R, Negri C, Prosperi E, Padovan L, Lavialle C, Brison O, Scovassi AI.

Oncogene. 1999 Jan 14;18(2):439-48.

33.

Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning.

Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, Parquet N, Maarek O, Noguera MH, Richard P, Brison O, Gluckman E.

Br J Haematol. 1998 Oct;103(1):249-55.

PMID:
9792317
34.

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation.

Socié G, Cayuela JM, Raynal B, Esperou H, Fund X, Raffoux C, Devergie A, Ribaud P, Marolleau JP, Parquet N, Sigaux F, Brison O, Gluckman E.

Leukemia. 1998 Sep;12(9):1440-6.

35.

Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia.

Meignin V, Devergie A, Brice P, Brison O, Parquet N, Ribaud P, Cojean I, Gaulard P, Gluckman E, Socie G, Janin A.

Transplantation. 1998 Feb 27;65(4):595-7. Review.

PMID:
9500643
36.

Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification.

Petit T, Dommergues M, Socié G, Dumez Y, Gluckman E, Brison O.

Br J Haematol. 1997 Sep;98(3):767-71.

PMID:
9332337
37.

Analysis of the size distribution of first-strand cDNA molecules.

Bodescot M, Brison O.

Biotechniques. 1997 Jun;22(6):1119-22, 1124-6.

38.

Characterization of new human c-myc mRNA species produced by alternative splicing.

Bodescot M, Brison O.

Gene. 1996 Sep 26;174(1):115-20.

PMID:
8863737
39.

Cloning and sequencing of a tpr-met oncogene cDNA isolated from MNNG-transformed human XP fibroblasts.

Wicker R, Bounacer A, Gascon A, Brison O, Sarasin A, Suárez HG.

Biochim Biophys Acta. 1995 Dec 27;1264(3):254-6.

PMID:
8547307
40.

A highly sensitive polymerase chain reaction method reveals the ubiquitous presence of maternal cells in human umbilical cord blood.

Petit T, Gluckman E, Carosella E, Brossard Y, Brison O, Socié G.

Exp Hematol. 1995 Dec;23(14):1601-5.

PMID:
8542953
41.

Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era.

Socie G, Lawler M, Gluckman E, McCann SR, Brison O.

Leuk Res. 1995 Aug;19(8):497-504. Review.

PMID:
7658696
42.
43.

IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line.

Lamonerie T, Lavialle C, Haddada H, Brison O.

Int J Cancer. 1995 May 16;61(4):587-92.

PMID:
7759165
44.
45.

[Value of the analysis of cellular chimerism following bone marrow graft by amplification of minisatellite sequences or specific of the Y chromosome].

Lasfargues G, Landman Parker J, Blaise A, Brison O, Leverger G.

Bull Acad Natl Med. 1995 Feb;179(2):357-65; discussion 365-6. French.

PMID:
7614063
46.

Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.

Lamonerie T, Lavialle C, de Galle B, Binoux M, Brison O.

Exp Cell Res. 1995 Feb;216(2):342-51.

PMID:
7531153
47.

Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation.

Petit T, Raynal B, Socié G, Landman-Parker J, Bourhis JH, Gluckman E, Pico J, Brison O.

Blood. 1994 Nov 15;84(10):3575-83.

PMID:
7949111
48.
49.

Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia.

Verschuur A, Brousse N, Raynal B, Brison O, Rohrlich P, Rahimy C, Vilmer E.

Bone Marrow Transplant. 1994 Sep;14(3):467-70.

PMID:
7994275
50.

Efficient second-strand cDNA synthesis using T7 DNA polymerase.

Bodescot M, Brison O.

DNA Cell Biol. 1994 Sep;13(9):977-85.

PMID:
7522464

Supplemental Content

Loading ...
Support Center